Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Allergy-Medication Firm Aimmune Gets Added $200 Million Nestlé Investment
By Tony Owusu
Feb 5, 2020 10:10 AM EST
PRESS RELEASES
Xencor Enters Collaboration With Janssen With Aim To Discover Novel CD28 Bispecific Antibodies For The Treatment Of Prostate Cancer
By Business Wire
Dec 7, 2020 8:01 AM EST
PRESS RELEASES
Xencor Presents Updated Data From The Phase 1 Study Of Vibecotamab In Acute Myeloid Leukemia At The 2020 ASH Annual Meeting
By Business Wire
Dec 6, 2020 5:00 PM EST
PRESS RELEASES
Xencor To Present At Upcoming Investor Conferences
By Business Wire
Nov 12, 2020 4:01 PM EST
PRESS RELEASES
Xencor, MorphoSys And Incyte Enter Into Global Development Collaboration For Tafasitamab In Combination With Plamotamab
By Business Wire
Nov 11, 2020 4:02 PM EST
PRESS RELEASES
Xencor Presents Data From Multiple Preclinical XmAb® Bispecific Antibody And Cytokine Programs At The SITC Annual Meeting
By Business Wire
Nov 9, 2020 8:00 AM EST
PRESS RELEASES
Xencor To Present Data From Phase 1 Study Of Vibecotamab In Acute Myeloid Leukemia At The 2020 ASH Annual Meeting
By Business Wire
Nov 4, 2020 10:15 AM EST
PRESS RELEASES
Xencor To Host Third Quarter 2020 Financial Results Webcast And Conference Call On November 5, 2020
By Business Wire
Oct 29, 2020 4:01 PM EDT
PRESS RELEASES
Xencor To Present Data From The Phase 1 Study Of XmAb®20717 And Three Research Programs At The SITC Annual Meeting
By Business Wire
Oct 14, 2020 5:00 PM EDT
PRESS RELEASES
Xencor Presents Initial Data From The Phase 1 Study Of Tidutamab In Neuroendocrine Tumors At NANETS' Multidisciplinary NET Medical Virtual Symposium
By Business Wire
Oct 2, 2020 9:00 AM EDT
PRESS RELEASES
Xencor To Present At The 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
By Business Wire
Sep 9, 2020 4:01 PM EDT
PRESS RELEASES
Xencor And MD Anderson Enter Strategic Collaboration To Advance Investigational XmAb® Drug Candidates
By Business Wire
Sep 3, 2020 8:01 AM EDT
PRESS RELEASES
Xencor To Present At Upcoming Investor Conferences
By Business Wire
Aug 5, 2020 4:01 PM EDT
PRESS RELEASES
Xencor Earns Milestone Payment From MorphoSys For FDA Approval Of Monjuvi® (tafasitamab-cxix) In The United States
By Business Wire
Jul 31, 2020 10:49 PM EDT
PRESS RELEASES
Xencor To Host Second Quarter 2020 Financial Results Webcast And Conference Call On August 4, 2020
By Business Wire
Jul 28, 2020 5:01 PM EDT
PRESS RELEASES
Atreca And Xencor Enter Strategic Collaboration To Discover, Develop And Commercialize Novel T Cell Engaging Bispecific Antibodies
By GlobeNewswire
Jul 8, 2020 8:01 AM EDT
PRESS RELEASES
Xencor And Atreca Enter Strategic Collaboration To Discover, Develop And Commercialize Novel T Cell Engaging Bispecific Antibodies
By Business Wire
Jul 8, 2020 8:01 AM EDT
PRESS RELEASES
Xencor Presents Data From Four Preclinical XmAb® 2 1 Bispecific Antibody And Cytokine Programs At AACR Virtual Annual Meeting II
By Business Wire
Jun 22, 2020 9:06 AM EDT
PRESS RELEASES
Xencor To Present At Upcoming Investor Conferences
By Business Wire
May 26, 2020 4:01 PM EDT
PRESS RELEASES
Xencor To Present Data From Four Preclinical XmAb® 2 1 Bispecific Antibody And Cytokine Programs At AACR Virtual Annual Meeting II
By Business Wire
May 15, 2020 12:01 AM EDT
PRESS RELEASES
Xencor To Present At The 2020 RBC Capital Markets Global Healthcare Virtual Conference
By Business Wire
May 13, 2020 9:01 AM EDT
PRESS RELEASES
Xencor To Host First Quarter 2020 Financial Results Webcast And Conference Call On May 7, 2020
By Business Wire
Apr 30, 2020 4:01 PM EDT
PRESS RELEASES
Xencor And Vir Biotechnology Enter License Agreement For Use Of Xtend™ XmAb® Antibody Technology In Investigational Antibodies To Treat COVID-19
By Business Wire
Mar 25, 2020 4:01 PM EDT
PRESS RELEASES
Xencor To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call On February 24, 2020
By Business Wire
Feb 18, 2020 8:01 AM EST
PRESS RELEASES
Xencor To Present At Upcoming Investor Conferences
By Business Wire
Feb 6, 2020 4:01 PM EST